1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Physician-lymphoma survivor discussions of health promotion: A qualitative analysis
    Meeting Abstract

    Blanch-Hartigan, D.; Shuk, E.; McLarney, K.; Philip, E. J.; Horwitz, S.; Bylund, C.
    Annals of Behavioral Medicine (2015)

    Fulltext@MSK | Save
  • Zebras and hen's teeth: Recognition and management of rare T and NK lymphomas
    Journal Article

    Mehta-Shah, N.; Horwitz, S.
    Hematology-American Society of Hematology Education Program (2015)

    Fulltext@MSK | Save
  • Hodgkin and non-Hodgkin lymphomas seen through their microenvironment: Impact on diagnosis, prognosis and innovative therapy
    Book Whole


    Future Medicine (2015)

    Fulltext@MSK | Save
  • Hodgkin and non-Hodgkin lymphomas seen through their microenvironment: Impact on diagnosis, prognosis and innovative therapy
    Book Whole


    Future Medicine (2015)

    Fulltext@MSK | Save
  • A phase 2 study of idelalisib monotherapy in previously untreated patients >= 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
    Meeting Abstract

    Zelenetz, A.; Lamanna, N.; Kipps, T.; Coutre, S.; O'Brien, S.; Graves, J.; Ye, W.; Dubowy, R.; Flinn, I.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Duvelisib (IPI-145), an oral dual inhibitor of PI3K-delta,gamma, is clinically active in patients with relapsed/refractory chronic lymphocytic leukemia
    Meeting Abstract

    O'Brien, S.; Patel, M.; Kahl, B.; Horwitz, S.; Foss, F.; Porcu, P.; McLaughlin, J.; Sweeney, J.; Allen, K.; Faia, K.; more...
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • Principles of chemotherapy in Hodgkin lymphoma
    Book Section

    Johnson, P.; Straus, D.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Targeting CD30 in patients with Hodgkin lymphoma
    Book Section

    Kumar, A.; Pileri, S.; Younes, A.; Engert, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Other new agents for Hodgkin lymphoma
    Book Section

    Moskowitz, A. J.; Younes, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save
  • Preface
    Book Section

    Andreas, E.; Younes, A.
    In Andreas, E.; Younes, A. (Eds.) Hodgkin Lymphoma: A Comprehensive Overview. 2nd ed (2015)

    Fulltext@MSK | Save